Clinical Impact of New Viral Hepatitis Data From AASLD 2022*

One of the biggest messages from AASLD 2022 was that we still have a lot of work to do. Between the pandemic and propagation of unhealthy behaviors, there’s still an incredible burden of liver disease, and viral hepatitis continues to contribute to it.

Nancy Reau, MD Released: December 2, 2022

There were many exciting developments in viral hepatitis presented at AASLD 2022, which makes me look forward to guideline updates to reflect evolving screening and therapeutic recommendations for HBV, HCV, and HDV.

Stefan Zeuzem, MD Released: December 5, 2022